BlackRock’s Neos Therapeutics, Inc NEOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-401,088
| Closed | -$251K | – | 5404 |
|
|
2020
Q4 | $251K | Buy |
401,088
+2,040
| +0.5% | +$1.26K | ﹤0.01% | 4441 |
|
|
2020
Q3 | $212K | Buy |
399,048
+24
| +0% | +$16 | ﹤0.01% | 4399 |
|
|
2020
Q2 | $274K | Sell |
399,024
-127,982
| -24% | -$101K | ﹤0.01% | 4315 |
|
|
2020
Q1 | $396K | Buy |
527,006
+1,170
| +0.2% | +$1.61K | ﹤0.01% | 4099 |
|
|
2019
Q4 | $794K | Sell |
525,836
-314
| -0.1% | -$471 | ﹤0.01% | 4061 |
|
|
2019
Q3 | $779K | Sell |
526,150
-4,099
| -0.8% | -$6.63K | ﹤0.01% | 4062 |
|
|
2019
Q2 | $684K | Sell |
530,249
-2,139,233
| -80% | -$3.94M | ﹤0.01% | 4118 |
|
|
2019
Q1 | $6.97M | Sell |
2,669,482
-63,929
| -2% | -$150K | ﹤0.01% | 3277 |
|
|
2018
Q4 | $4.51M | Buy |
2,733,411
+610,660
| +29% | +$1.71M | ﹤0.01% | 3424 |
|
|
2018
Q3 | $10.3M | Buy |
2,122,751
+31,469
| +2% | +$178K | ﹤0.01% | 3223 |
|
|
2018
Q2 | $13.1M | Buy |
2,091,282
+255,037
| +14% | +$1.9M | ﹤0.01% | 3103 |
|
|
2018
Q1 | $15.2M | Sell |
1,836,245
-25,102
| -1% | -$240K | ﹤0.01% | 2909 |
|
|
2017
Q4 | $19M | Buy |
1,861,347
+436,667
| +31% | +$4.19M | ﹤0.01% | 2811 |
|
|
2017
Q3 | $13M | Buy |
1,424,680
+448,341
| +46% | +$3.41M | ﹤0.01% | 3018 |
|
|
2017
Q2 | $7.13M | Buy |
976,339
+78,615
| +9% | +$594K | ﹤0.01% | 3344 |
|
|
2017
Q1 | $6.46M | Buy |
897,724
+897,241
| +185,764% | +$5.57M | ﹤0.01% | 3293 |
|
|
2016
Q4 | $3K | Hold |
483
| – | – | ﹤0.01% | 3619 |
|
|
2016
Q3 | $3K | Hold |
483
| – | – | ﹤0.01% | 3586 |
|
|
2016
Q2 | $4K | Buy |
483
+395
| +449% | +$3.77K | ﹤0.01% | 3554 |
|
|
2016
Q1 | $1K | Buy |
+88
| New | +$928 | ﹤0.01% | 3593 |
|
BlackRock's NEOS Position: Q1 2021 in Review
BlackRock sold out of Neos Therapeutics, Inc (NEOS) in Q1 2021, closing a stake of 401,088 shares — an estimated $251K sold.
BlackRock first reported a position in NEOS in Q1 2016 and held it in 20 quarters. The position peaked at $19M in Q4 2017. 0 funds tracked by Wall St. Rank hold NEOS as of Q1 2021.
- BlackRock reported no remaining Neos Therapeutics, Inc position as of Q1 2021 after selling out during the quarter.
- BlackRock sold 401,088 Neos Therapeutics, Inc shares in Q1 2021, an estimated $251K.
- BlackRock first reported a position in Neos Therapeutics, Inc in Q1 2016 and held it in 20 quarters.
- BlackRock's Neos Therapeutics, Inc position peaked at $19M in Q4 2017.
- 0 funds tracked by Wall St. Rank held Neos Therapeutics, Inc as of Q1 2021.
Based on BlackRock's 13F filing for Q1 2021, filed 7 May 2021.